跳至主要内容
临床试验/NCT00818597
NCT00818597已完成1 期

PhaseI/II Study of the Safety and Efficacy of the Use of Granulocyte-Concentrates Applied in Extracorporeal Circulation Devices-the EISS-1 Study

University of Rostock2 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2003年12月1日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
10
试验地点
2
主要终点
single organ functions (circulation, kidney, lung, liver)

研究概览

简要总结

The purpose of this study is to investigate the effect of an extracorporeal application of a bed-side bioreactor containing human donor granulocytes on the course and outcome of septic shock in humans.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • sepsis with at least one organ failure (severe sepsis) or septic shock

排除标准

  • Participation in another study within the last 30 days
  • Earlier participation in this study
  • Pregnancy
  • Bleeding, clinically not controlled (needing more than 2 red blood cell-transfusions per day)
  • Hemodynamic shock for more than 12 hours (systolic BP <90mmHg) despite adequate therapy
  • HIV infection
  • HCV infection, active

结局指标

主要结局

single organ functions (circulation, kidney, lung, liver)

时间窗: 28day post inclusion

次要结局

  • survival(28day post inclusion)

研究者

发起方
University of Rostock
申办方类型
Other

研究点 (2)

Loading locations...

相似试验